<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55012764"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<note type="other">original article<lb/></note>

	<reference>T h e ne w e ngl a nd jou r na l o f m e dic i ne<lb/> n engl j med 361;10 nejm.org september 3, 2009<lb/></reference>

	<note type="page">968<lb/></note>

	<docTitle>
	<titlePart>Injectable Collagenase Clostridium<lb/> Histolyticum for Dupuytren&apos;s Contracture<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>Lawrence C. Hurst, M.D., Marie A. Badalamente, Ph.D., Vincent R. Hentz, M.D.,<lb/> Robert N. Hotchkiss, M.D., F. Thomas D. Kaplan, M.D., Roy A. Meals, M.D.,<lb/> Theodore M. Smith, Ph.D., and John Rodzvilla, M.D.,<lb/></docAuthor>
	</byline>

	<note type="other">for the CORD I Study Group*<lb/> From the State University of New York<lb/> (SUNY) at Stony Brook, Stony Brook<lb/> (L.C.H., M.A.B.); Stanford Hospitals and<lb/> Clinics, Palo Alto, CA (V.R.H.); the Hospi-<lb/>tal for Special Surgery, New York (R.N.H.);<lb/> the Indiana Hand Center, Indianapolis<lb/> (F.T.D.K.); Los Angeles (R.A.M.); and<lb/> Auxilium Pharmaceuticals, Malvern, PA<lb/> (T.M.S., J.R.). Address reprint requests to<lb/> Dr. Hurst at the Department of Ortho-<lb/>paedics, SUNY at Stony Brook, Health<lb/> Science Center, Level 18, Rm. 020, Stony<lb/> Brook, NY 11794-8181, or at lhurst@notes.<lb/> cc.sunysb.edu.<lb/> *Members of the Collagenase Option for<lb/> Reduction of Dupuytren&apos;s (CORD) I Study<lb/> Group are listed in the Supplementary<lb/> Appendix, available with the full text of<lb/> this article at NEJM.org.<lb/> </note>

	<reference>N Engl J Med 2009;361:968-79.<lb/></reference>

	<note type="copyright">Copyright Â© 2009 Massachusetts Medical Society.<lb/></note>

	<note type="other">A BS TR AC T<lb/> Background</note>

		</front>
	</text>
</tei>
